Implantable Flow Restrictor with Biodegradable Linkages

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Abrupt restoration of blood flow after an interventional procedure can cause reperfusion injury to downstream tissue due to sudden increases in oxidative and shear stresses, leading to damage and complications such as apoptosis.

Innovation Solution

An implantable medical device with a self-expanding annular member and biodegradable linkages that initially restrict and then gradually expand to allow controlled restoration of blood flow, transforming from a frustoconical to a cylindrical shape to prevent tissue overload, using biodegradable materials that dissolve over time to facilitate gradual expansion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If blood flow is abruptly restored after an interventional procedure, then patency is restored to the blood vessel, but reperfusion injury occurs to downstream tissue due to sudden oxidative and shear stresses

Engineering Contradiction:
Improvevessel patency restorationVSAvoidreperfusion injury to downstream tissue
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The flow restrictor device transitions from a static flow restriction to a dynamic gradual expansion mechanism. The biodegradable linkages progressively dissolve over time, allowing the annular member to dynamically expand and increase blood flow incrementally. This dynamic transformation enables the device to adapt its flow restriction level as healing progresses, preventing sudden reperfusion injury while maintaining initial flow control.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The device utilizes parameter changes in the biodegradable linkage material over time. As the linkages degrade and dissolve, the structural parameters of the device change, transitioning from a constrained frustoconical shape to an expanded cylindrical shape. This parameter evolution controls the blood flow rate progressively, allowing tissue adaptation to increasing flow without abrupt changes that would cause reperfusion injury.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If a flow restrictor device is used to gradually restore blood flow, then reperfusion injury is prevented, but the device structure becomes more complex with additional components

Engineering Contradiction:
Improvereperfusion injury preventionVSAvoiddevice structure complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The flow restrictor device merges multiple functions into a single integrated structure. The annular member combines flow restriction, gradual expansion capability, and structural support functions. The biodegradable linkages integrate the timing mechanism and expansion actuation without requiring separate control systems. This merging approach achieves gradual flow restoration while minimizing device complexity compared to mechanically controlled expansion systems.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The device employs self-service through the automatic biodegradation of the linkages. The material inherently degrades over time without requiring external intervention, surgical removal, or active control mechanisms. The dissolution process naturally drives the expansion sequence, eliminating the need for complex actuation systems while achieving the desired gradual flow restoration and reperfusion injury prevention.

Inventive Principle:
Principle #25Self-service

3Duration of action of moving object

If the annular member is initially constrained to reduce blood flow, then tissue adaptation time is provided, but the constraining linkages must be temporary and require dissolution or removal

Engineering Contradiction:
Improvetissue adaptation timeVSAvoidlinkage temporary structure requirement
Core Design Contradiction:
Duration of action of moving objectVSEase of manufacture

Solution Approach 1:

The biodegradable linkages utilize parameter changes in their material properties over time. The material transitions from an intact load-bearing state to a degraded dissolved state through controlled biodegradation. This parameter evolution provides the necessary temporary constraint duration for tissue adaptation while ultimately eliminating the need for surgical removal, as the linkages naturally dissolve after serving their flow control function.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device reduces the risk of reperfusion injury by allowing tissue to adapt to increasing blood flow, minimizing damage and complications by controlling the restoration of blood flow over time, thereby ensuring safer vascular recovery post-procedure.

Implementation Method 1

the linkages are biodegradable and dissolve in vivo

Methodology Applied
Scientific EffectBiodegradation: Decomposition (biological)

Implementation Method 2

the linkages are biodegradable and dissolve in vivo

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 3

A self-expanding annular member is attached to the outlet

Methodology Applied
Scientific EffectElastic recovery: Elastic Recovery

Data Source

PatentUS9060891B2Implantable temporary flow restrictor device
Publication Date: 2015.06.23 MEDTRONIC VASCULAR INC
  • US9060891B2 patent drawing
  • US9060891B2 patent drawing
  • US9060891B2 patent drawing

AI summary

An implantable flow restrictor device is disclosed for initially restricting, then gradually restoring blood flow through a body vessel after an interventional procedure. A self-expanding annular member having a constricted diameter gives the device a frustoconical configuration that reduces blood flow therethrough upon initial deployment at a treatment site. The annular member is constricted by a plurality of linkages that operate to allow the annular member to gradually expand, thereby transforming the flow restrictor device to a cylindrical configuration that allows unimpeded blood flow therethrough. In one embodiment, expansion of the annular member is achieved via biodegradation of the linkages. In another embodiment, expansion of the annular member is achieved via creep deformation of the linkages. The flow restrictor device may be attached to an endoluminal prosthesis, or may be a separate complementary component that is delivered during an interventional procedure.